Caligiuri M P, Heindel W C, Lohr J B
Department of Psychiatry, University of California, San Diego.
Ann Neurol. 1992 Jan;31(1):53-8. doi: 10.1002/ana.410310110.
It has been known for some time that patients with Parkinson's disease (PD) have difficulty executing simultaneous motor acts, yet the pathophysiology underlying this impairment remains uncertain. We examined the possibility that these dual-task deficits stem from defective sensorimotor mechanisms producing interference between the motor programs underlying the two tasks. Patients with PD and normal control subjects were tested on their ability to maintain steady-state force with one hand while performing a force-reaction time task with the other hand. Although performance was worse on the dual-task than on the single-task condition for both subject groups, only the patients with PD demonstrated significant interference between the two tasks. The interference across tasks improved in 87% of the patients with PD when tested after treatment with carbidopa/levodopa (Sinemet). These findings support the contention that, in patients with PD, disturbances in the execution of simultaneous motor performance may be due to sensorimotor disinhibition.
一段时间以来,人们已经知道帕金森病(PD)患者在执行同时进行的运动行为时存在困难,但这种损伤背后的病理生理学仍不确定。我们研究了这些双任务缺陷是否源于有缺陷的感觉运动机制,这种机制会在两个任务所基于的运动程序之间产生干扰。对帕金森病患者和正常对照受试者进行测试,以考察他们用一只手维持稳态力量的同时,用另一只手执行力量反应时间任务的能力。虽然两个受试组在双任务条件下的表现都比单任务条件下差,但只有帕金森病患者在两个任务之间表现出显著干扰。在用卡比多巴/左旋多巴(息宁)治疗后进行测试时,87%的帕金森病患者的任务间干扰得到改善。这些发现支持了这样的观点,即帕金森病患者同时进行运动表现时的执行障碍可能是由于感觉运动去抑制。